At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 247 enrolled
Drug / intervention
Dexamethasone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery
In Brief
A Phase 3 clinical trial evaluating Dexamethasone and Punctum Plug for Post Ocular Surgical Inflammation and Pain. Completed, enrolled 247 participants across 1 site.
Detailed Summary
To evaluate the safety and efficacy of OTX-DP as a sustained release drug (dexamethasone) depot when placed in the canaliculus of the eyelid for the treatment of post-surgical inflammation and pain in subjects who have undergone cataract extraction with intra-ocular lens implantation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 2014
Enrollment StartFeb 2014
Primary CompletionDec 2014
Study CompletionFeb 2015
TodayJul 2026
First PostedJan 13, 2014
Enrollment StartFeb 1, 2014
Primary CompletionDec 1, 2014
Study CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 12.5 years ago
Interventions
Dexamethasonedrug
Punctum Plugdrug